Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-23
2005-08-23
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S205000, C548S236000
Reexamination Certificate
active
06933309
ABSTRACT:
A halogenobenzylaminopropionic acid derivative represented by the following formula (1):or a pharmaceutically acceptable salt of the derivative, and a drug containing the same as an active ingredient for treating diabetes, hyperlipidemia, or similar pathological conditions.
REFERENCES:
patent: 96/38415 (1996-12-01), None
patent: 97/31907 (1997-09-01), None
patent: 00/08002 (2000-02-01), None
Diabetes Care (US), American Diabetes Association, vol. 21, pp. 641-648 1998.
The Lancet (UK), Lancet, vol. 357, pp. 905-910 2001.
Kahn et al. DIABETOLOGY (DE), European Association for Study of Diabetes, vol. 39 (suppl), p. A53 1996.
G. Riccardi et al., “Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes,”Atherosclerosis, 75 (1989), Elsevier Scientific Publishers Ireland, Ltd., pp. 175-181.
G. Paragh et al., “Treatment Possibility of Hypercholesterolaemia Associated with Hypertriglyceridaemia,”Acta Biologica Hungarica48 (3) (1997), pp. 359-367.
M. Yoshinari et al., “Effect of gemfibrozil on serum levels of prostacycin and precursor fatty acids in hyperlipidemic patients with Type 2 diabetes,” Diabetes Research and Clinical Practice 42 (1998), pp. 149-154.
Y. Kawamatsu et al., “Studies on Antihyperlipidemic Agents,” Central Research Division, Takeda Chemical Industries, Ltd., Osaka (Japan) pp. 454-459.
Kazayama Shin-ichi
Ohnuma Shin-ya
Takayanagi Koichi
Yamada Hideki
Saeed Kamal A.
Toaeiyo Ltd.
LandOfFree
Halogenobenzyl aminopropionic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Halogenobenzyl aminopropionic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Halogenobenzyl aminopropionic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3522431